NMS·Healthcare·$190M·#110 / 520 in Healthcare
INGN Inogen, Inc
63SOLID
CATEGORY BREAKDOWN
GROWTH6
QUALITY43
STABILITY98
VALUATION100
GOVERNANCE76
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+3.9%
6
> 50% strong
Gross Margin
Revenue retained after direct costs
44.2%
61
> 50% strong
Cash Runway
Months of cash at current burn rate
111 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
9.1%
93
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.5x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
-5
16
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
11.8%
69
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.6%
90
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE INGN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when INGN's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.